Published in J Exp Med on December 23, 2013
BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia. Mol Cell (2015) 1.36
Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia. Cell Stem Cell (2015) 1.09
C/EBPα in normal and malignant myelopoiesis. Int J Hematol (2015) 1.06
C/EBPα creates elite cells for iPSC reprogramming by upregulating Klf4 and increasing the levels of Lsd1 and Brd4. Nat Cell Biol (2016) 0.91
OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action. Bioinformatics (2014) 0.88
C/EBPα: critical at the origin of leukemic transformation. J Exp Med (2014) 0.87
Amplification of pico-scale DNA mediated by bacterial carrier DNA for small-cell-number transcription factor ChIP-seq. BMC Genomics (2015) 0.86
Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia. Exp Hematol (2014) 0.84
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors. Genes Dev (2015) 0.82
The deregulated expression of miR-125b in acute myeloid leukemia is dependent on the transcription factor C/EBPα. Leukemia (2015) 0.81
TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemia. Leukemia (2014) 0.79
ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiation. Genes Dev (2015) 0.78
The Janus-faced Nature of miR-22 in Hematopoiesis: Is It an Oncogenic Tumor Suppressor or Rather a Tumor-Suppressive Oncogene? PLoS Genet (2017) 0.77
The presence of C/EBPα and its degradation are both required for TRIB2-mediated leukaemia. Oncogene (2016) 0.77
Targeting CDK6 in cancer: State of the art and new insights. Cell Cycle (2015) 0.76
The multifaceted functions of C/EBPα in normal and malignant haematopoiesis. Leukemia (2015) 0.75
Frequency of 11q23/MLL gene rearrangement in Egyptian childhood acute myeloblastic leukemia: Biologic and clinical significance. South Asian J Cancer (2014) 0.75
Prognostic Significance of Mixed-Lineage Leukemia (MLL) Gene Detected by Real-Time Fluorescence Quantitative PCR Assay in Acute Myeloid Leukemia. Med Sci Monit (2016) 0.75
The full transforming capacity of MLL-Af4 is interlinked with lymphoid lineage commitment. Blood (2017) 0.75
The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis. J Hematol Oncol (2017) 0.75
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 235.12
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 101.91
Inducible gene targeting in mice. Science (1995) 21.22
Restoration of p53 function leads to tumour regression in vivo. Nature (2007) 12.62
MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer (2007) 8.17
Acute myeloid leukaemia. Lancet (2006) 7.74
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell (2006) 6.34
Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J (1998) 5.21
Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J Clin Oncol (2010) 4.09
Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity (2004) 3.84
Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization. Mol Cell Biol (2004) 3.62
Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA (2010) 3.25
The diverse functions of Dot1 and H3K79 methylation. Genes Dev (2011) 2.66
The molecular biology of mixed lineage leukemia. Haematologica (2009) 2.58
C/EBPalpha mutations in acute myeloid leukaemias. Nat Rev Cancer (2004) 2.40
NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements. Genes Dev (2008) 2.26
The pathogenesis of mixed-lineage leukemia. Annu Rev Pathol (2011) 1.95
Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein. Mol Cell Biol (2004) 1.94
Gene set enrichment analysis made simple. Stat Methods Med Res (2009) 1.79
MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome. Blood (2011) 1.74
Disruption of the c/ebp alpha gene in adult mouse liver. Mol Cell Biol (1997) 1.72
Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy. Proc Natl Acad Sci U S A (2006) 1.20
RNA-seq analysis of 2 closely related leukemia clones that differ in their self-renewal capacity. Blood (2010) 1.17
Molecular mechanisms underlying deregulation of C/EBPalpha in acute myeloid leukemia. Int J Hematol (2010) 0.98
Phosphorylation of serine 248 of C/EBPα is dispensable for myelopoiesis but its disruption leads to a low penetrant myeloid disorder with long latency. PLoS One (2012) 0.79
Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes. Nucleic Acids Res (2010) 2.37
NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements. Genes Dev (2008) 2.26
Effects of NOD-like receptors in human B lymphocytes and crosstalk between NOD1/NOD2 and Toll-like receptors. J Leukoc Biol (2010) 1.62
PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2. Nat Neurosci (2012) 1.58
C/EBPalpha: a tumour suppressor in multiple tissues? Biochim Biophys Acta (2006) 1.33
A novel partial modification at C2501 in Escherichia coli 23S ribosomal RNA. RNA (2004) 1.33
HemaExplorer: a database of mRNA expression profiles in normal and malignant haematopoiesis. Nucleic Acids Res (2012) 1.29
ImmunoGrid, an integrative environment for large-scale simulation of the immune system for vaccine discovery, design and optimization. Brief Bioinform (2009) 1.19
Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML. Blood (2011) 1.17
ImmunoGrid: towards agent-based simulations of the human immune system at a natural scale. Philos Trans A Math Phys Eng Sci (2010) 1.16
HemaExplorer: a Web server for easy and fast visualization of gene expression in normal and malignant hematopoiesis. Blood (2012) 1.11
Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients. Blood (2013) 1.09
B cell activation by outer membrane vesicles--a novel virulence mechanism. PLoS Pathog (2010) 1.09
The proline-histidine-rich CDK2/CDK4 interaction region of C/EBPalpha is dispensable for C/EBPalpha-mediated growth regulation in vivo. Mol Cell Biol (2006) 0.93
Temporal mapping of CEBPA and CEBPB binding during liver regeneration reveals dynamic occupancy and specific regulatory codes for homeostatic and cell cycle gene batteries. Genome Res (2013) 0.92
The IgD-binding domain of the Moraxella IgD-binding protein MID (MID962-1200) activates human B cells in the presence of T cell cytokines. J Leukoc Biol (2005) 0.89
spliceR: an R package for classification of alternative splicing and prediction of coding potential from RNA-seq data. BMC Bioinformatics (2014) 0.88
Technical advance: immunophenotypical characterization of human neutrophil differentiation. J Leukoc Biol (2011) 0.85
Lack of the p42 form of C/EBPα leads to spontaneous immortalization and lineage infidelity of committed myeloid progenitors. Exp Hematol (2013) 0.81
Intestinal transporters for endogenic and pharmaceutical organic anions: the challenges of deriving in-vitro kinetic parameters for the prediction of clinically relevant drug-drug interactions. J Pharm Pharmacol (2012) 0.80
The IgD CH1 region contains the binding site for the human respiratory pathogen Moraxella catarrhalis IgD-binding protein MID. Eur J Immunol (2006) 0.77
Gaboxadol has affinity for the proton-coupled amino acid transporter 1, SLC36A1 (hPAT1)--A modelling approach to determine IC(50) values of the three ionic species of gaboxadol. Eur J Pharm Sci (2010) 0.76
Simulating kinetic parameters in transporter mediated permeability across Caco-2 cells. A case study of estrone-3-sulfate. Eur J Pharm Sci (2011) 0.75
C/EBPalpha in leukemogenesis: identity and origin of the leukemia-initiating cell. Biofactors (2009) 0.75
Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors. Cell (2016) 0.75
[Transgenic mice as disease models]. Ugeskr Laeger (2003) 0.75